scholarly journals  Comparative single intraperitoneal dose pharmacokinetics of aspirin and acetaminophen in chicks

2012 ◽  
Vol 57 (No. 3) ◽  
pp. 121-124 ◽  
Author(s):  
FK Mohammad ◽  
AS Mansoor ◽  
MHI Al-Zubaidy
Keyword(s):  
Intraperitoneal Administration ◽  
Compartmental Analysis ◽  
The Body ◽  
Pharmacokinetic Parameters ◽  
Limited Information ◽  
Spectrophotometric Methods ◽  
Elimination Half ◽  
Toxicological Studies ◽  
Intraperitoneal Dose ◽  
Total Body

Limited information is available on the pharmacokinetics and bioavailability of aspirin and acetaminophen in young chicks. The purpose of the present study was to examine the pharmacokinetics of acetyl salicylic acid (aspirin) and acetaminophen in 12-day old chicks after a single intraperitoneal administration of each drug alone at the dose of 100 mg/kg body weight. Blood samples were collected from chicks (six/each time period) at 10, 20, 30, 60 and 120 min after each drug administration. The concentrations of aspirin and acetaminophen in the plasma were determined by spectrophotometric methods. The pharmacokinetic parameters of the drugs were calculated by a non-compartmental analysis. The elimination half-lives of aspirin and acetaminophen were 1.68 and 1.36 h with steady state volume of distributions 0.079 and 1.11 l/kg and total body clearances of 0.029 and 0.53 l/h/kg, respectively. The mean residence times of the drugs were 2.74 and 2.09 h and their area under the plasma concentration-time curves (0–∞) were 3486 and 188 μg/h/ml, respectively. In conclusion, the data show the pharmacokinetic profiles of single intraperitoneal doses of aspirin and acetaminophen in chicks and suggest that acetaminophen is well distributed in the body of the chicks and eliminated faster from the body compared to aspirin. These parameters should be taken into consideration in further therapeutic and toxicological studies of drugs in chickens.  

Vancomycin Disposition following Intraperitoneal Administration in Children Receiving Peritoneal Dialysis

2007 ◽  
Vol 27 (1) ◽  
pp. 79-85 ◽  
Author(s):  
Douglas L. Blowey ◽  
Bradley A. Warady ◽  
Susan Abdel–Rahman ◽  
Reginald F. Frye ◽  
Harold J. Manley
Keyword(s):  
Peritoneal Dialysis ◽  
Total Body Clearance ◽  
Intraperitoneal Administration ◽  
Primary Objective ◽  
Pharmacokinetic Parameters ◽  
Vancomycin Concentration ◽  
Elimination Half ◽  
Serum Vancomycin ◽  
Total Body ◽  
Body Clearance

Background Little information is available on the disposition of vancomycin during chronic peritoneal dialysis (PD) in children. The primary objective of this study was to investigate the disposition of vancomycin following intraperitoneal (IP) administration in children receiving short-dwell [ e.g., automated PD (APD)] and long-dwell [ e.g., continuous ambulatory PD (CAPD)] PD. Methods A 6-hour exchange containing vancomycin 500 mg/L, using an exchange volume of 1100 mL/m2 body surface area (BSA), was followed by 4-, 6-, and 8-hour antibiotic-free exchanges. The 8-hour exchange was followed by three to four 90-minute antibiotic-free exchanges. Serial blood and dialysis effluent samples were obtained and analyzed for vancomycin concentration by high-pressure liquid chromatography. Pharmacokinetic parameters were computed using noncompartmental methods. Results The bioavailability of vancomycin during a 6-hour IP exchange was 70% ± 5%, resulting in a delivered dose of 12.0 ± 1.8 mg/kg, and a 6-hour serum vancomycin concentration of 23.3 ± 7.2 μg/mL. Total body vancomycin clearance measured 10.72 ± 4.52 mL/minute/1.73 m2 BSA, while clearance attributable to PD measured 2.78 ± 1.08 mL/min/1.73 m2 BSA and accounted for 29% ± 11% of total vancomycin clearance. Dialysis clearance during long-dwell (CAPD) and short-dwell (APD) regimens was similar, measuring 2.46 ± 1.04 and 3.09 ± 1.28 mL/min/1.73 m2 BSA, accounting for 25% ± 13% and 32% ± 12% of total body clearance respectively. Conclusions Intraperitoneal absorption and dialysis clearance of vancomycin in children receiving PD are similar to those reported in adult dialysis patients. In contrast, total body clearance of vancomycin appears to be increased and the elimination half-life decreased in children, due to increased elimination by non-renal nondialysis routes. For intermittent IP vancomycin therapy in children with peritonitis, an IP load containing vancomycin 1000 mg/L (or 30 mg/kg), followed a single full-fill (1100 mL/m2 BSA) daily exchange, containing vancomycin 250 mg/L (or 7.5 mg/kg), from day 2 until the end of treatment will maintain a vancomycin dialysate concentration of >4 μg/mL.

PROSPECTS FOR INTRODUCTION OF THE THREE-COMPONENT COORDINATION COMPOUND OF HERMANIUM OXYETHYLIDENED DIPHOSPHONATE WITH NICOTIC ACID IN THE BOUNDARIES WITH IN STUDYING OF THEIR PHARMACOKINETICS

2021 ◽  
Author(s):  
A. G. Vidavskaya ◽  
S. B. Strechen
Keyword(s):  
Coordination Compound ◽  
Intraperitoneal Administration ◽  
The Body ◽  
Biologically Active ◽  
Pharmacokinetic Parameters ◽  
Photometric Method ◽  
Pharmacokinetic Studies ◽  
Experimental Animals ◽  
Elimination Half ◽  
Male Wistar Rats

The purpose of this work is to experimentally study the pharmacokinetics of a three-component coordination compound of germanium oxyethylidene diphosphonate with nicotinic acid (MIGU-4), created on the basis of natural metabolites. The study of the pharmacokinetics of MIGU-4 was carried out for germanium and was based on the extraction-photometric method. The experiment was carried out on male Wistar rats weighing 130-170 g. MIGU-4 was injected intraperitoneally at the rate of 37.5 mg of germanium per 1 kg of body weight. Its amount in tissues was determined photometrically by the light absorption of germanium phenifluoronate. The results of the experimental study were processed statistically. Pharmacokinetic parameters calculated using partial models analyzing the pharmacokinetic parameters, it can be seen that MIGU-4 was rapidly distributed over the organs and tissues of experimental animals. The time of admission to the examined organs was less than 0,25 hours. The studied biologically active substance quickly enters the well-vascularized organs and is evenly distributed in them. The elimination half-life (T1|2) was 5 - 8 h, the largest in the lungs, the smallest in the liver. The average residence time of MIGU-4 in experimental animals ranged from 7 hours to 27 hours. Therefore, with intraperitoneal administration of MIGU-4 is rapidly excreted from the body. The results of pharmacokinetic studies have shown that MIGU-4 is promising for the creation of a safe and effective drug. The dynamics of the therapeutic effect is comparable to the maximum concentration of the substance in the organs and tissues of experimental animals.

Removal of Vancomycin during Plasmapheresis

1997 ◽  
Vol 31 (10) ◽  
pp. 1132-1136 ◽  
Author(s):  
Syble D McClellan ◽  
Charles H Whitaker ◽  
Richard C Friedberg
Keyword(s):  
Tertiary Care ◽  
Compartment Model ◽  
The Body ◽  
Patient Specific ◽  
Pharmacokinetic Parameters ◽  
Serum Concentrations ◽  
Total Clearance ◽  
Concentration Data ◽  
Vancomycin Concentration ◽  
Total Body

OBJECTIVE: To examine the removal of vancomycin during plasmapheresis, determine whether drug administration should be withheld prior to or a supplemental dose given after the procedure, and determine whether a redistribution phenomenon in vancomycin serum concentrations occurs after plasmapheresis. DESIGN: Prospective, cohort study. SETTING: An 800-bed, tertiary-care, teaching hospital. PATIENTS: Twelve patients receiving vancomycin as prescribed who were also undergoing therapeutic plasmapheresis. METHODS: Blood samples for determination of vancomycin concentrations were obtained from each patient immediately before, during, immediately after, and 2 hours after plasmapheresis. Vancomycin concentration in plasma removed by plasmapheresis and volume of plasma removed were measured. Patient-specific pharmacokinetic parameters were determined for each patient using serum concentration data and a one-compartment model. Percent of drug removed by plasmapheresis and percent increase in vancomycin total clearance secondary to plasmapheresis were calculated. RESULTS: A mean of 6.3% of the total body store of vancomycin was removed by plasmapheresis. Vancomycin clearance during plasmapheresis averaged 1.6 L/h, which was an average increase of 285% in the total clearance of vancomycin from the body. Nine of 10 patients had a higher observed vancomycin concentration 2 hours after plasmapheresis than that predicted by degrading the concentration observed immediately after the procedure, suggesting that redistribution in serum concentrations occurs after the procedure. CONCLUSIONS: A single one-volume plasmapheresis does not remove a clinically important amount of vancomycin; therefore, supplemental dosing after the procedure is not necessary. A redistribution phenomenon in vancomycin concentrations appears to exist after plasmapheresis. Further study is needed to determine how long the redistribution phase lasts and when vancomycin concentrations should be measured after plasmapheresis.

scholarly journals Pharmacokinetics of Intravenous Piperacillin Administration in Patients Undergoing On-Line Hemodiafiltration

2009 ◽  
Vol 53 (8) ◽  
pp. 3266-3268 ◽  
Author(s):  
Kook-Hwan Oh ◽  
Chiweon Kim ◽  
Hankyu Lee ◽  
Hajeong Lee ◽  
Ji Yong Jung ◽  
...  
Keyword(s):  
Standard Deviation ◽  
Total Body Clearance ◽  
Volume Of Distribution ◽  
Pharmacokinetic Parameters ◽  
Recovery Method ◽  
Elimination Half ◽  
On Line ◽  
The Mean ◽  
Total Body ◽  
Body Clearance

ABSTRACT The pharmacokinetic characteristics of piperacillin sodium were studied in five volunteers undergoing on-line hemodiafiltration (HDF). The subjects were given 2 g of piperacillin sodium intravenously over 1 min and placed on on-line HDF for 4 h starting at 60 min after the piperacillin infusion. Noncompartmental models were employed for estimation of the pharmacokinetic parameters, and intradialytic piperacillin clearance was calculated by the recovery method. The mean volume of distribution and the elimination half-life were 0.27 ± 0.13 liter/kg (mean ± standard deviation) and 1.1 ± 0.6 h, respectively. The total body clearance of piperacillin was 0.19 ± 0.08 liter/h/kg. Piperacillin clearance through on-line HDF was 0.11 ± 0.06 liter/h/kg. The mean serum piperacillin concentration was 4.0 ± 1.9 μg/ml at the end of the 4-h on-line HDF session. The concentration of infused piperacillin recovered in the dialysate was 527 ± 236 mg (26.3% ± 11.8%). We suggest the replacement of 500 mg of piperacillin after each on-line HDF session.

scholarly journals Disposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats

2011 ◽  
Vol 2011 ◽  
pp. 1-5
Author(s):  
Harshad B. Patel ◽  
Shailesh K. Mody ◽  
Hitesh B. Patel ◽  
Vipul A. Patel ◽  
Urvesh D. Patel
Keyword(s):  
Drug Concentration ◽  
Half Life ◽  
Total Body Clearance ◽  
Volume Of Distribution ◽  
The Body ◽  
Maximum Plasma ◽  
Elimination Half Life ◽  
Elimination Half ◽  
Total Body ◽  
Body Clearance

The present study was carried out to investigate disposition kinetics of moxifloxacin following single-dose intravenous (i.v.), intramuscular (i.m.), and subcutaneous (s.c.) administration at a dose rate of 5 mg/kg of body weight (b.wt.) in goats. Plasma samples collected after treatments were analyzed for drug concentration using high-performance liquid chromatography (HPLC). After i.v. administration, distribution of the drug was rapid and wide as reflected by high steady-state volume of distribution. Drug elimination was relatively faster with a total body clearance of 0.59±0.03 L/h/kg. Following i.m. injection, the drug has shown the rapid and near-to-complete absorption with bioavailability of 98.20±3.96 per cent. The maximum plasma drug concentration (Cmax) of 1.21±0.04 μg/mL was attained at 1 h (Tmax). The drug was widely distributed as reflected by high apparent volume of distribution. The elimination half-life (t1/2β) of the drug was 6.26±0.08  h. Following s.c. administration, the drug was rapidly absorbed (Cmax: 1.16±0.02 μg/mL; tmax: 1 h) and slowly eliminated from the body. The elimination half-life and total body clearance (ClB) were 5.61±0.10 h and 0.60±0.03 L/h/kg, respectively. The bioavailability of moxifloxacin following s.c. administration was 90.44±3.96 per cent.

scholarly journals Body composition in professional female netball players within and between seasons: a cohort study

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Luke Hogarth ◽  
Ava Farley ◽  
Max McKenzie ◽  
Brendan Burkett ◽  
Mark McKean
Keyword(s):  
Body Composition ◽  
Body Mass ◽  
Fat Mass ◽  
Lean Mass ◽  
The Body ◽  
Limited Information ◽  
Mineral Density ◽  
Preparation Period ◽  
Total Body ◽  
Composition Changes

Abstract Background There is limited information on the physique attributes of female netball players from the highest playing standards and the typical body composition changes that occur with training and competition in these athletes. The purpose of this study was to examine the body composition of professional female netball players and changes that occur within and between national premier netball seasons. Methods Dual-energy X-ray absorptiometry (DXA) assessments were conducted in 20 female netball players (age = 26.5 [4.7] years, body mass = 77.3 [9.7] kg, stature = 182.7 [9.5] cm) contracted to a Suncorp Super Netball team. Total body lean mass, fat mass, bone mass and bone mineral density were derived for 127 assessments collected over three seasons. Linear mixed effects modelling was used to examine changes in body composition measures within and between seasons. Results Goal circle players were heavier (12.3 [3.5] kg, p < 0.001, g = 1.51) and taller (15.0 [2.7] cm, p < 0.001, g = 2.30) than midcourt players, and midcourt players had greater lean mass (3.1 [1.6] %, p = 0.07, g = 0.85) and less fat mass (-3.3 [1.7] %, p = 0.06, g = -0.84) than goal circle players when values were normalised to body mass. Players achieved increases in lean mass (2,191 [263] g, p < 0.01, g = 0.45) and decreases in fat mass (-835 [351] g, p = 0.09, g = -0.16) following a preseason preparation period. There were no changes in lean mass (-394 [295] g, p = 0.54, g = 0.07) or fat mass (102 [389] g, p = 0.99, g = 0.04) from the start to the end of the 14-week competition period. Conclusions Professional female netball players achieve small changes in lean mass and fat mass during preseason preparation and maintain their physique over the competitive season. The results of this study can inform practitioners on the training content necessary to promote or maintain desired body composition changes in these athletes.

scholarly journals Comparative study on Pharmacokinetic Profiles of Chicken IgY to Horse IgG in Rabbits

2018 ◽  
Vol 68 (3) ◽  
pp. 405
Author(s):  
ZHAOXIANG ZHOU ◽  
JIAN WANG ◽  
SONG GAO ◽  
HAO REN ◽  
WENYAN XIE ◽  
...  
Keyword(s):  
Tetanus Toxoid ◽  
Indirect Elisa ◽  
Compartmental Analysis ◽  
The Body ◽  
Rabbit Serum ◽  
Pharmacokinetic Parameters ◽  
White Leghorn ◽  
White Leghorn Chicken ◽  
Pharmacokinetic Profiles ◽  
Egg Yolks

Chicken IgY antibody has been extensively reported for various applications as an alternative to mammalian IgG. To evaluated the pharmacokinetics profile of chicken IgY in comparison with horse IgG. Chicken IgY antibody was prepared by immunizing the white leghorn chicken with tetanus toxoid (TT) and then extracted anti-TT-IgY from immune egg yolks by PEG-6000 extraction. The titer of anti-TT-IgY was determined by ELISA in order to select the hyper immune eggs for further extraction. Rabbits were injected with 300 μg/kg of Chicken IgY and horse IgG by intravenous (i.v.) and intramuscular (i.m.) administrations. Then, the concentrations of IgY and IgG in rabbit serum were determined using indirect ELISA. Pharmacokinetic parameters were estimated using non-compartmental analysis. IgY can reach higher concentration (Cmax= 4.54 mg/L after i.m. injection) within shorter time (Tmax= 0.12 h after i.m. injection) than IgG (Cmax= 3.99 ng/mL after i.m. injection; Tmax=0.11 h after i.m. injection), while the IgY lifespan (T1/2=26.98 h and 31.98 h after i.v. and i.m. administration, respectively) in the body was comparable with IgG (T1/2=27.94 h and 29.58 h after i.v. and i.m. administration, respectively). IgY might be a promising choice as an alternative to mammalian sourced antibodies.

scholarly journals Pharmacokinetics of Doxycycline in Ducks with Steatosis due to Force-feeding

2016 ◽  
Vol 39 (2) ◽  
pp. 219-224 ◽  
Author(s):  
Neno Bratoev ◽  
Aneliya Milanova ◽  
Ivelina Pavlova ◽  
Lubomir Lashev
Keyword(s):  
Compartmental Analysis ◽  
Serum Levels ◽  
Volume Of Distribution ◽  
Hplc Method ◽  
Absolute Bioavailability ◽  
Pharmacokinetic Parameters ◽  
Control Group ◽  
Serum Concentrations ◽  
Maximum Serum ◽  
Total Body

AbstractThe pharmacokinetics of doxycycline was investigated in force-fed and normally fed ducks after single intravenous (i.v.) and oral (p.o.) administration at a dose of 15 mg/kg bw. Serum concentrations of the drug were determined by the HPLC method. Pharmacokinetic parameters were calculated using compartmental analysis. Serum concentrations of doxycycline after i.v. administration in both groups were not statistically different. The values of half-lives were 5.82±1.85 h and 6.06±5.51 h in normal and force-fed birds. The total body clearance was respectively 0.40±0.05 L/h/kg and 0.34±0.10 L/h/kg, and volume of distribution (Vss) was 2.80±0.85 L/kg and 2.18±0.89 L/kg. After p.o. administraton the maximum serum levels in the control group were 0.70±0.12 μg/mL and in force-fed birds were 1.93±0.32 μg/mL, measured at 2.95±0.60 h and 1.45±0.24 h, respectively. The values of absolute bioavailability were 18.89±6.48% and 37.58±13.63%. Longer doxycycline retention in force-fed ducks was registered. Our data can be accepted as an information for possible prolonged retention of doxycycline in force fed ducks compared to normally fed ones.

scholarly journals Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration

2020 ◽  
Vol 7 ◽  
Author(s):  
Jeff D. Olivarez ◽  
Amanda J. Kreuder ◽  
Dane M. Tatarniuk ◽  
Larry W. Wulf ◽  
Katarzyna A. Dembek ◽  
...  
Keyword(s):  
Half Life ◽  
Plasma Clearance ◽  
Compartmental Analysis ◽  
Pharmacokinetic Parameters ◽  
Pharmacokinetic Data ◽  
Tissue Samples ◽  
Elimination Half Life ◽  
Elimination Half ◽  
Edible Tissues ◽  
Neonatal Calves

Background: Neonatal calves are at risk of developing abomasal ulceration, but there is a lack of pharmacokinetic data for potential anti-ulcerative therapies, such as pantoprazole, in ruminant species.Objective: The study objectives were to estimate plasma pharmacokinetic parameters for pantoprazole in neonatal dairy calves after intravenous (IV) administration. A secondary objective was to quantify the concentrations of pantoprazole in edible tissues after IV dosing.Methods: Pantoprazole was administered to 9 neonatal Holstein calves at a dose of 1 mg/kg IV. Plasma samples were collected over 24 h and analyzed via HPLC-MS for determining pantoprazole concentrations. Pharmacokinetic parameters were derived via non-compartmental analysis. Tissue samples were collected at 1, 3, and 5 days after administration and analyzed via HPLC-MS.Results: Following IV administration, plasma clearance, elimination half-life, and volume of distribution of pantoprazole were estimated at 4.46 mL/kg/min, 2.81 h, and 0.301 L/kg, respectively. The global extraction ratio was estimated at 0.053 ± 0.015. No pantoprazole was detected in the edible tissues 1, 3, or 5 days after administration. A metabolite, pantoprazole sulfone was detected in all the edible tissues 1 and 3 days after administration.Conclusion: The reported plasma clearance for pantoprazole is less than that reported for alpacas but higher than reported in foals. The elimination half-life in calves appears to be longer than observed in foals and alpacas. While pantoprazole sulfone was detected in the tissues after IV administration, further research is needed as to the metabolism and potential tissue accumulation of other pantoprazole metabolites in calves. Future pharmacodynamic studies are necessary to determine the efficacy of pantoprazole on abomasal acid suppression in calves.

scholarly journals Bioavailability pharmacokinetics and residues of marbofloxacin in normal and E.coli infected broiler chicken

2016 ◽  
Vol 4 (2) ◽  
pp. 144
Author(s):  
Ashraf El-Komy ◽  
Taha Attia ◽  
Amera Abd El Latif ◽  
Hanem Fathy
Keyword(s):  
Oral Administration ◽  
Half Life ◽  
Broiler Chickens ◽  
Volume Of Distribution ◽  
Pharmacokinetic Parameters ◽  
Maximum Serum ◽  
Elimination Half Life ◽  
Elimination Half ◽  
Total Body

The pharmacokinetics of marbofloxacin was studied following a single intravenous, oral administration in normal broiler chickens and repeated oral administrations in normal and experimentally E.coli infected broiler chickens. The pharmacokinetic parameters following a single intravenous injection of 2 mg/kg b.wt., revealed that marbofloxacin obeyed a two compartments open model, distribution half-life (t0.5(α)) was 0.25±0.02 h, volume of distribution (Vdss) was 0.76±0.08 L/kg, elimination half-life (t0.5(β)) was 5.43±0.87 h and total body clearance (CLtot) was 0.09±0.002 l/kg/h. Following a single oral administration, marbofloxacin was rapidly and efficiently absorbed through gastrointestinal tract of chickens as the absorption half-life (t0.5 (ab): 0.62±0.02 h). Maximum serum concentration (Cmax) was 1.15±0.01 μg/ml, reached its maximum time (tmax) at 2.53±0.04 h, elimination half-life (t0.5 (el)) was 7.36±0.20 h indicating the tendency of chickens to eliminate marbofloxacin in slow rate. Oral bioavailability was 73.57± 1.90 % indicating good absorption of marbofloxacin after oral administration. Serum concentrations of marbofloxacin following repeated oral administration of 2 mg/kg b.wt. once daily for five consecutive days, peaked 2 hours after each oral dose with lower significant values recorded in experimentally infected broiler chickens than in normal ones. Tissues residues of marbofloxacin in slaughtered normal chickens was highly in those tissues lung, liver, and kidneys in chickens and the chicken must not be slaughtered before 3 days of stopping of drug administration. It was concluded that the in- vitro protein binding was 12.33±0.82%.

Sign in / Sign up

Export Citation Format

Share Document